Results 111 to 120 of about 458,337 (361)
Preoperative Detection of Dual TERT Promoter Mutations in Thyroid Cancer: A Case Series
Diagnostic Cytopathology, EarlyView.ABSTRACT Telomerase reverse transcriptase promoter (TERTp) mutations are associated with aggressive thyroid cancer and are most frequently found in anaplastic and poorly differentiated thyroid cancer. Pre‐operative thyroid nodule molecular testing can detect TERTp, denoting a high risk of malignancy and possible aggressive clinical features such as ...
Amir Harari +7 more
wiley +1 more source
Iodinated Contrast Medium Affects Urine Cytology Assessment: A Prospective, Single-Blind Study and Its Impact on Urological Practice [PDF]
, 2022 Milan Král +7 more
openalex +1 more source
Diagnostic Cytopathology, EarlyView.ABSTRACT This report introduces Dr. Sara E. Monaco, the incoming President‐Elect of the American Society of Cytopathology (ASC) and System Director of Cytopathology at Geisinger Medical Center. Dr. Monaco has provided significant mentorship to me over the years and facilitated the development of my passion for cytopathology and education.
Terrance J. Lynn
wiley +1 more source
Diagnostic Cytopathology, EarlyView.ABSTRACT Background Folate receptor‐⍺ (FR‐⍺) is an attractive target for targeted therapy. Mirvetuximab soravtansine (MIRV) has been approved by the United States Food and Drug Administration (FDA) for treating adult patients with FR‐⍺ positive, platinum‐resistant epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Therefore,
Yadan Ma +5 more
wiley +1 more source
Evaluation of the COVID-19 Lockdown-Adapted Online Methodology for the Cytology and Histology Course as Part of the Degree in Veterinary Medicine [PDF]
, 2022 Ana Balseiro +3 more
openalex +1 more source
Cytology versus HPV testing for cervical cancer screening in the general population.
Cochrane Database of Systematic Reviews, 2017 G. Koliopoulos +8 more
semanticscholar +1 more source
Diagnostic Cytopathology, EarlyView.ABSTRACT Malignant mesothelioma (MM) is a rare yet aggressive neoplasm that arises from mesothelial cells lining the thoracic and abdominal cavities, the pericardium, and the tunica testis. Characterized by rapid progression, high invasiveness, and a poor prognosis, MM poses significant clinical challenges. SMARCB1, also referred to as INI‐1, hSNF5, or
Jun Yang +4 more
wiley +1 more source
The Bethesda System for Reporting Cervical Cytology: A Historical Perspective
Acta Cytologica, 2017 R. Nayar, D. Wilbur, D. Solomon
semanticscholar +1 more source
Analysis of SWI Complex Subunits in 69 Cases of TTF‐1 Negative Non‐Small Cell Lung Carcinoma
Diagnostic Cytopathology, EarlyView.ABSTRACT Non‐small cell lung carcinomas, not otherwise specified (NSCLC‐NOS) with a specific signature including high‐grade hepatoid/clear cell morphology, negative lung panel mutational analysis, negative TTF‐1/Napsin A staining can be reported as a morphologic variant of an aggressive carcinoma with loss of one of the subunits of the SWI/SNF ...
Ramin Zargham +2 more
wiley +1 more source